BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 26022121)

  • 21. Preparation and characterization of chitosan/β-cyclodextrin nanoparticles containing plasmid DNA encoding interleukin-12.
    Nahaei M; Valizadeh H; Baradaran B; Nahaei MR; Asgari D; Hallaj-Nezhadi S; Dastmalchi S; Lotfipour F
    Drug Res (Stuttg); 2013 Jan; 63(1):7-12. PubMed ID: 23447042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor cells with B7.1 and transmembrane anchored staphylococcal enterotoxin A generate effective antitumor immunity.
    Si SY; Hu PZ; Huang YY; Ye J; Huang Y; Li ZS; Ge W; Li X; Qu P; Zhang XM; Sui YF
    Biochem Biophys Res Commun; 2006 Aug; 347(1):208-14. PubMed ID: 16814254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective efficacy of a Treponema pallidum Gpd DNA vaccine vectored by chitosan nanoparticles and fused with interleukin-2.
    Zhao F; Wang S; Zhang X; Gu W; Yu J; Liu S; Zeng T; Zhang Y; Wu Y
    Can J Microbiol; 2012 Feb; 58(2):117-23. PubMed ID: 22260167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delivery of NKG2D ligand using an anti-HER2 antibody-NKG2D ligand fusion protein results in an enhanced innate and adaptive antitumor response.
    Cho HM; Rosenblatt JD; Tolba K; Shin SJ; Shin DS; Calfa C; Zhang Y; Shin SU
    Cancer Res; 2010 Dec; 70(24):10121-30. PubMed ID: 21159634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydrogel nanoparticle encapsulated plasmid as a suitable gene delivery system.
    Rafieei A; Riazi-Rad F; Alimohammadian MH; Gazori T; Fatemi SM; Havaskary M
    Tsitol Genet; 2015; 49(2):16-20. PubMed ID: 26030969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel self-assembled nanoparticle vaccine with HIV-1 Tat₄₉₋₅₇/HPV16 E7₄₉₋₅₇ fusion peptide and GM-CSF DNA elicits potent and prolonged CD8⁺ T cell-dependent anti-tumor immunity in mice.
    Tang J; Yin R; Tian Y; Huang Z; Shi J; Fu X; Wang L; Wu Y; Hao F; Ni B
    Vaccine; 2012 Feb; 30(6):1071-82. PubMed ID: 22178528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MICA/NKG2D-mediated immunogene therapy of experimental gliomas.
    Friese MA; Platten M; Lutz SZ; Naumann U; Aulwurm S; Bischof F; Bühring HJ; Dichgans J; Rammensee HG; Steinle A; Weller M
    Cancer Res; 2003 Dec; 63(24):8996-9006. PubMed ID: 14695218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma.
    Niethammer AG; Xiang R; Ruehlmann JM; Lode HN; Dolman CS; Gillies SD; Reisfeld RA
    Cancer Res; 2001 Aug; 61(16):6178-84. PubMed ID: 11507070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor efficacy induced by human ovarian cancer cells secreting IL-21 alone or combination with GM-CSF cytokines in nude mice model.
    Dou J; Wang Y; Wang J; Zhao F; Li Y; Cao M; Hu W; Hu K; He XF; Chu L; Jiang C; Gu N
    Immunobiology; 2009; 214(6):483-92. PubMed ID: 19389515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chitosan-thioglycolic acid conjugate: an alternative carrier for oral nonviral gene delivery?
    Martien R; Loretz B; Thaler M; Majzoob S; Bernkop-Schnürch A
    J Biomed Mater Res A; 2007 Jul; 82(1):1-9. PubMed ID: 17265441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel DNA vaccine constructed by heat shock protein 70 and melanoma antigen-encoding gene 3 against tumorigenesis.
    Qu P; Ma JH; Zhang XM; Huang XJ; Yang XW; Yan-Fang S
    Indian J Exp Biol; 2010 May; 48(5):436-43. PubMed ID: 20795360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Immunogenicity of CRISP1 Plasmid-Based Contraceptive Vaccine can be Improved When Using Chitosan Nanoparticles as the Carrier.
    Luo J; Liu XL; Zhang Y; Wang YQ; Xu WM; Yang J
    Am J Reprod Immunol; 2016 Jun; 75(6):643-53. PubMed ID: 27105782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of immunity by a DNA melanoma vaccine against TRP2 with CCL21 as an adjuvant.
    Yamano T; Kaneda Y; Huang S; Hiramatsu SH; Hoon DS
    Mol Ther; 2006 Jan; 13(1):194-202. PubMed ID: 16112911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvanticity of plasmid DNA encoding cytokines fused to immunoglobulin Fc domains.
    Ferrone CR; Perales MA; Goldberg SM; Somberg CJ; Hirschhorn-Cymerman D; Gregor PD; Turk MJ; Ramirez-Montagut T; Gold JS; Houghton AN; Wolchok JD
    Clin Cancer Res; 2006 Sep; 12(18):5511-9. PubMed ID: 17000687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation on the anti-tumor efficacy by expression of GPI-anchored mIL-21 on the surface of B16F10 cells in C57BL/6 mice.
    Zhao F; Dou J; Wang J; Chu L; Tang Q; Wang Y; Li Y; Cao M; Hu W; Hu K; Feng He X; Gu N
    Immunobiology; 2010; 215(2):89-100. PubMed ID: 19457579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of murine Lewis lung cancer with recombinant interleukin-12].
    Yin XL; Duan H; Peng ZP; Sun SL; Li SL
    Ai Zheng; 2006 Sep; 25(9):1087-91. PubMed ID: 16965647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Transformation activity and antigenicity of the human papillomavirus type 58 E6E7 fusion gene mutant].
    Wang H; Yu JY; Li L
    Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):491-6. PubMed ID: 24257298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo.
    Tahara H; Zeh HJ; Storkus WJ; Pappo I; Watkins SC; Gubler U; Wolf SF; Robbins PD; Lotze MT
    Cancer Res; 1994 Jan; 54(1):182-9. PubMed ID: 7903204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mannosylated protamine as a novel DNA vaccine carrier for effective induction of anti-tumor immune responses.
    Zeng Z; Dai S; Jiao Y; Jiang L; Zhao Y; Wang B; Zong L
    Int J Pharm; 2016 Jun; 506(1-2):394-406. PubMed ID: 27106528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.